Literature DB >> 6161916

Stringent response of Bacillus stearothermophilus: evidence for the existence of two distinct guanosine 3',5'-polyphosphate synthetases.

S Fehr, D Richter.   

Abstract

Bacillus stearothermophilus reacted to pseudomonic acid-induced inhibition of isoleucine-transfer ribonucleic acid (RNA) acylation and to energy downshift caused by alpha-methylglucoside addition with accumulation of guanosine 3',5'-polyphosphates [(p)ppGpp] and restriction of RNA synthesis. In vitro studies indicated that (p)ppGpp was synthesized by two different enzymes. One enzyme, (p)ppGpp synthetase I, was present in the ribosomal fraction, required the addition of a ribosome-messenger RNA-transfer RNA complex for activation, and was inhibited by tetracycline and thiostrepton. It is suggested that (p)ppGpp synthetase I is comparable to the relA gene product from Escherichia coli and is responsible for (p)ppGpp accumulation during amino acid starvation. The other enzyme, (p)ppGpp synthetase II, was found in the high-speed supernatant fraction (S100). It functioned independently of ribosomes, transfer RNA, and messenger RNA and was not inhibited by the above-mentioned antibiotics. (p)ppGpp synthetase II is thought to be responsible for (p)ppGpp accumulation during carbon source downshift. The two enzymes differ in their Km values for adenosine triphosphate (ATP):2mM ATP for synthetase I and 0.05 mM ATP for synthetase II. They also have different molecular weights: apparent Mr of 86,000 (+/- 5,000) for synthetase I and 74,000 (+/- 5,000) for synthetase II.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161916      PMCID: PMC217245          DOI: 10.1128/jb.145.1.68-73.1981

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  11 in total

1.  The guanosine 3',5'-bis(diphosphate) (ppGpp) cycle. Comparison of synthesis and degradation of guanosine 3',5'-bis(diphosphate) in various bacterial systems.

Authors:  D Richter; S Fehr; R Harder
Journal:  Eur J Biochem       Date:  1979-08-15

2.  STUDIES ON THE GLUCOSE-TRANSPORT SYSTEM IN ESCHERICHIA COLI WITH ALPHA-METHYLGLUCOSIDE AS SUBSTRATE.

Authors:  H HAGIHIRA; T H WILSON; E C LIN
Journal:  Biochim Biophys Acta       Date:  1963-11-15

3.  The competitive inhibition of alpha-methylglucoside uptake in Escherichia coli.

Authors:  D P KESSLER; H V RICKENBERG
Journal:  Biochem Biophys Res Commun       Date:  1963-03-25       Impact factor: 3.575

Review 4.  Stringent control in E. coli.

Authors:  J A Gallant
Journal:  Annu Rev Genet       Date:  1979       Impact factor: 16.830

5.  Mechanism of the in vitro breakdown of guanosine 5'-diphosphate 3'-diphosphate in Escherichia coli.

Authors:  E A Heinemeyer; D Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

6.  Degradation of guanosine 3'-diphosphate 5'-diphosphate in vitro by the spoT gene product of Escherichia coli.

Authors:  E A Heinemeyer; M Geis; D Richter
Journal:  Eur J Biochem       Date:  1978-08-15

Review 7.  Genetics of bacterial ribosomes.

Authors:  M Nomura; E A Morgan
Journal:  Annu Rev Genet       Date:  1977       Impact factor: 16.830

8.  The role of energy-generating processes in the degradation of guanosine tetrophosphate, ppGpp, in Escherichia coli.

Authors:  H A De Boer; A J Bakker; W J Weyer; M Gruber
Journal:  Biochim Biophys Acta       Date:  1976-05-19

9.  Development of defined and minimal media for the growth of Bacillus stearothermophilus.

Authors:  J J Rowe; I D Goldberg; R E Amelunxen
Journal:  J Bacteriol       Date:  1975-10       Impact factor: 3.490

10.  Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid.

Authors:  J Hughes; G Mellows
Journal:  Biochem J       Date:  1978-10-15       Impact factor: 3.857

View more
  11 in total

Review 1.  Control of rRNA synthesis in Escherichia coli: a systems biology approach.

Authors:  Patrick P Dennis; Mans Ehrenberg; Hans Bremer
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

Review 2.  Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Ward; D M Campoli-Richards
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

3.  Physiological analysis of the stringent response elicited in an extreme thermophilic bacterium, Thermus thermophilus.

Authors:  Koji Kasai; Tomoyasu Nishizawa; Kosaku Takahashi; Takeshi Hosaka; Hiroyuki Aoki; Kozo Ochi
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

4.  Studies in vivo on Escherichia coli RNA polymerase mutants altered in the stringent response.

Authors:  E Baracchini; R Glass; H Bremer
Journal:  Mol Gen Genet       Date:  1988-08

5.  High intracellular level of guanosine tetraphosphate in Mycobacterium smegmatis changes the morphology of the bacterium.

Authors:  A K Ojha; T K Mukherjee; D Chatterji
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Involvement of the stringent response in degradation of glutamine phosphoribosylpyrophosphate amidotransferase in Bacillus subtilis.

Authors:  M E Ruppen; R L Switzer
Journal:  J Bacteriol       Date:  1983-07       Impact factor: 3.490

7.  Degradation of aspartate transcarbamylase in Bacillus subtilis is deficient in rel mutants but is not mediated by guanosine polyphosphates.

Authors:  R W Bond; R L Switzer
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

8.  The role of guanosine-3',5'-bis-pyrophosphate in mediating antimicrobial activity of the antibiotic 3,5-dihydroxy-4-ethyl-trans-stilbene.

Authors:  L Sundar; F N Chang
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 9.  Control of rRNA transcription in Escherichia coli.

Authors:  C Condon; C Squires; C L Squires
Journal:  Microbiol Rev       Date:  1995-12

10.  Functional analysis of a relA/spoT gene homolog from Streptococcus equisimilis.

Authors:  U Mechold; M Cashel; K Steiner; D Gentry; H Malke
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.